Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Total Liabilities
Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has total liabilities worth CN¥1.04 Billion CNY (≈ $152.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Guangdong Zhongsheng Pharmaceutical Co L's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Guangdong Zhongsheng Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Guangdong Zhongsheng Pharmaceutical Co L (002317) total assets.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
National Storage REIT
AU:NSR
|
Australia | AU$2.49 Billion |
|
Becle S.A.B. de C.V
MX:CUERVO
|
Mexico | MX$34.26 Billion |
|
AIR CHINA LTD H ADR/20
F:AD2B
|
Germany | €303.54 Billion |
|
Brederode SA
BR:BREB
|
Belgium | €1.19 Million |
|
Virbac SA
PA:VIRP
|
France | €750.28 Million |
|
Vidrala SA
MC:VID
|
Spain | €1.05 Billion |
|
Red Rock Resorts Inc
NASDAQ:RRR
|
USA | $4.07 Billion |
|
Schneider National Inc
NYSE:SNDR
|
USA | $1.94 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Guangdong Zhongsheng Pharmaceutical Co L's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Zhongsheng Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.54 Billion ≈ $225.84 Million |
-20.15% |
| 2023-12-31 | CN¥1.93 Billion ≈ $282.84 Million |
-1.33% |
| 2022-12-31 | CN¥1.96 Billion ≈ $286.64 Million |
+43.63% |
| 2021-12-31 | CN¥1.36 Billion ≈ $199.57 Million |
+18.64% |
| 2020-12-31 | CN¥1.15 Billion ≈ $168.22 Million |
-16.22% |
| 2019-12-31 | CN¥1.37 Billion ≈ $200.78 Million |
+6.08% |
| 2018-12-31 | CN¥1.29 Billion ≈ $189.27 Million |
+14.90% |
| 2017-12-31 | CN¥1.13 Billion ≈ $164.73 Million |
+40.50% |
| 2016-12-31 | CN¥801.23 Million ≈ $117.24 Million |
-34.57% |
| 2015-12-31 | CN¥1.22 Billion ≈ $179.18 Million |
+200.39% |
| 2014-12-31 | CN¥407.63 Million ≈ $59.65 Million |
+71.24% |
| 2013-12-31 | CN¥238.04 Million ≈ $34.83 Million |
+58.25% |
| 2012-12-31 | CN¥150.41 Million ≈ $22.01 Million |
+62.55% |
| 2011-12-31 | CN¥92.54 Million ≈ $13.54 Million |
-3.13% |
| 2010-12-31 | CN¥95.53 Million ≈ $13.98 Million |
-11.92% |
| 2009-12-31 | CN¥108.46 Million ≈ $15.87 Million |
-23.90% |
| 2008-12-31 | CN¥142.53 Million ≈ $20.86 Million |
-14.74% |
| 2007-12-31 | CN¥167.17 Million ≈ $24.46 Million |
+9.32% |
| 2006-12-31 | CN¥152.93 Million ≈ $22.38 Million |
-- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.